Navigation Links
Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

headache (27%), vomiting (25%), peripheral edema (23%), rash (22%), diarrhea (22%), myalgia (19%), cough (19%), asthenia (18%), pruritus (17%), back pain (17%), anorexia (15%), arthralgia (14%) and upper respiratory tract infection (13%).

The percentage of patients reporting serious adverse events (SAEs) was higher for ONTAK than for placebo. Drug-related SAEs in ONTAK-treated patients were capillary leak syndrome (4%), dehydration (4%), hypotension (3%), fever (3%), hypoalbuminemia (2%), skin disorder (2%), chest pain (2%), vascular fragility (2%), fatigue (2%), hypersensitivity (2%), myocardial ischemia (1%), urinary tract infection (1%), blood pressure decreased (1%), joint stiffness (1%), myalgia (1%), carpel tunnel syndrome (1%), loss of consciousness (1%), respiratory distress (1%), dermatitis exfoliative (1%), erythema (1%), and rash generalized (1%). The frequency of SAEs decreased after the first two cycles of treatment. The percentage of patients overall who discontinued the study due to an adverse event was higher in the ONTAK group (20.0%) compared with the placebo group (9.1%).

"We are pleased that research continues with ONTAK in the treatment of patients with CTCL," said Judy Jones, Executive Director of the Cutaneous Lymphoma Foundation. "This study reflects Eisai's ongoing commitment to satisfying unmet medical needs in oncology, particularly in CTCL, a form of cancer for which there is no cure."

About ONTAK(R) (denileukin diftitox)

ONTAK is a genetically engineered fusion toxin protein consisting of the amino acid sequences for the enzymatically-active portion of diphtheria toxin fused to the sequence of human interleukin-2, resulting in a molecule that is cytotoxic for cells bearing the target IL-2 receptor expressed on malignant cells.

ONTAK is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL) whose malignant cells express the CD25 component of the IL-2 recepto
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
2. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
3. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
4. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
5. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
6. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
7. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
8. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
11. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
Post Your Comments:
(Date:3/6/2015)... , March 6, 2015  The German Court of Appeal ... LLY ) vitamin regimen patent for Alimta® (pemetrexed disodium) would ... market a dipotassium salt form of pemetrexed in ... 2015. The German Court ruled in favor ... and Company v. Actavis. This decision vacated the prior decision ...
(Date:3/6/2015)... , March 6, 2015  Par Pharmaceutical Companies, ... conference call on Friday, March 13, 2015 at ... operations for the fourth quarter and full year ... and currently makes certain financial information available to ... and Exchange Commission and will make certain other ...
(Date:3/6/2015)... , Alemania, 6 de marzo de 2015 /PRNewswire/ ... soluciones de gestión empresarial de imagen médica, fortalece ... el nombramiento de Randolph Sternberg como ... como director de operaciones. Logo ... Sternberg será responsable de las ventas y ...
Breaking Medicine Technology:German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 3TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3
... ThermoGenesis Corp. (Nasdaq: KOOL ), a leading ... store adult stem cells, said today it has entered ... 60 BMC (Res-Q) System with BioParadox, Inc., a newly-formed ... Under the agreement, ThermoGenesis is granting BioParadox ...
... U.S. Food and Drug Administration today approved Pradaxa ... and blood clots in patients with abnormal heart ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... 2 million Americans, involves very fast and uncoordinated ...
Cached Medicine Technology:ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 2ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 3FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation 2
(Date:3/6/2015)... US Sports Football Camps expands its network ... non-contact specialty camps and one contact football camp. The ... located at Bowie State University and Riverdale Baptist School. ... speed and strength of football athletes. The contact football ... Graves, former quarterback in the Canadian Football League, as ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... a national shortfall of 90,000 doctors by 2025 is ... Susquehanna Health (SH) is proactively preparing by analyzing ... and patient access. , Several factors including the ... number of insured under the Affordable Care Act and ...
(Date:3/6/2015)... First Choice Emergency Room opened its new ... at 13351 W. Bowles Avenue, Littleton, Colorado and is open ... to provide the highest quality emergency medical care to the ... Choice Emergency Room Littleton. , First Choice Emergency ... Chamber of Commerce and a medical community open house yesterday. ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend Report ... and statistics on one of the nation’s biggest drivers ... Management will discuss key findings from the report in ... Spend,” a complimentary March 19 webinar, managed and moderated ... makes up more than a quarter of total drug ...
(Date:3/6/2015)... NC (PRWEB) March 06, 2015 In a ... of Polish mesothelioma patients reported that shoulder pain was their ... story on its website. Click here to read it ... Warsaw analyzed the medical records of 49 mesothelioma patients ... them reported that it was shoulder pain that first prompted ...
Breaking Medicine News(10 mins):Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... of biological pathways could lead to treatments for other ... Researchers have discovered seven common DNA variations that increase ... which links the skin condition and psoriatic arthritis to ... 4 in the open-access journal PLoS Genetics , ...
... 11, 2008) During Wednesdays Satellite Symposium 3: ... (CF) at the International Society of Heart and ... clinicians and researchers discussed some of the unique ... patients with CF. , A highlight of the ...
... April 15, 2008, at, ------------------------------------------------------------------------ ... 10:00 ... Dr. Francesco Bellini,Chairman, President and Chief Executive Officer of Neurochem ... management, cordially invite,you to attend the Company,s Annual and Special ...
... of CNA Leaders, LOS ANGELES, April 11 ... the Service,Employees International Union for targeting CNA/NNOC leaders ... home and in patient care,units at hospitals., ... largest RN union --,demanded SEIU International President Andrew ...
... significantly superior to 16 slice multidetector CT in ... abdominal aortic aneurisms (EVAR), according to a recent ... in Bellinzona, Switzerland. , Endovascular repair of ... treatment to open surgery for many patients. Endoleak ...
... feelings of anxiety, worry, distress and insecurity face a risk ... to a unique study led by a University of Rochester ... not developed for people with these personality traits by the ... Duberstein, Ph.D., professor of psychiatry who led the study. But ...
Cached Medicine News:Health News:Researchers Identify New Genetic Links to Psoriasis 2Health News:Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT 2Health News:Neurochem Annual and Special Meeting of shareholders 2Health News:Neurochem Annual and Special Meeting of shareholders 3Health News:RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors 2Health News:RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors 3Health News:RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors 4Health News:MRI better than MDCT in detecting endoleaks, study says 2Health News:Personality study shows risk of first depression episode late in life 2
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Cost-effective otoscope with xenon halogen illumination. Polycarbonate molded head. Acrylic viewing window with 3X magnification. Nasal and spreadable specula avaliable....
The Pneumatic Consulting Otoscope provides two viewing lenses for dual observation of the tympanic membrane. Sealed system for pneumnatic otoscopy and rotatable head for left- and right-sided viewin...
... Shandon Cryotome FE and FSE are a ... Electron. The microtome is outside of the ... as well as faster temperature adjustment. Simple, ... Complete temperature controls on the main touch-screen ...
Medicine Products: